Core Viewpoint - The article discusses the focus of fund managers on semiconductor equipment and technology sectors, highlighting the performance of key fund managers and their investment strategies in these areas [4][20]. Fund Manager Performance - Fund managers Xie Zhiyu and Qiao Qian have significant management scales of 38.6 billion and 24 billion respectively, with annualized returns of 18% and 13.52% since their tenure began [4]. - Xie Zhiyu's fund, Xingquan Helun Mixed A, achieved a return of 35.7% in 2025, outperforming the CSI 300 index by 18 percentage points [4][5]. - Qiao Qian's fund, Xingquan Business Model Mixed A, recorded a return of 38.05% in 2025, with a net value growth exceeding 10% in early 2026 [5][6]. Investment Focus - Both fund managers are concentrating on technology sectors, particularly overseas computing power and semiconductor equipment [8][9]. - Xie Zhiyu maintains a high equity position, with 92.5% of the fund's net value in stocks by the end of the fourth quarter [11]. - Qiao Qian's fund also operates with a high equity position of 94.4% at the end of the fourth quarter [16]. Portfolio Adjustments - Xie Zhiyu's fund saw significant changes in its top holdings, with the introduction of storage testing and module leader Baiwei Storage, which is expected to see a net profit growth of 427%-520% in 2025 [12]. - New entries in the top ten holdings for Xie Zhiyu include semiconductor equipment stocks Tuo Jing Technology and Huahai Qingke, while North China Innovation, Lens Technology, and Focus Media exited the list [13]. - Qiao Qian's fund also adjusted its top holdings significantly, with six new entries, including Baiwei Storage and Huahai Qingke, while North China Innovation and Lens Technology were removed [17]. Overall Market Outlook - The two fund managers agree on the positive outlook for technology sectors, particularly semiconductor equipment, storage, and overseas computing power [20].

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [2]. Core Insights - In Q4 2025, the overall allocation of public funds in the chemical sector has significantly increased, indicating a bottoming out and potential investment opportunities [2]. - The top ten chemical stocks held by public funds saw a recovery in their market value share, with a notable increase in the proportion of leading blue-chip stocks, suggesting a preference for stable investments in cyclical products with price elasticity [2][12]. - The total market value of the top 30 chemical stocks held by public funds reached approximately 79.89 billion, reflecting a significant increase of about 45.23% compared to the previous quarter [24]. Summary by Sections 1. Q4 2025 Public Fund Chemical Holdings Changes - The proportion of heavy chemical stocks in overall public fund holdings increased by 0.70 percentage points to 2.37%, marking a new high for 2025 [7]. - Regional allocations also saw increases, with East China rising by 0.63 percentage points to 2.33%, South China by 0.96 percentage points to 3.02%, and North China by 0.44 percentage points to 1.44% [7]. 2. Changes in the Number of Funds Holding Chemical Stocks - The number of funds holding chemical stocks increased significantly, driven mainly by blue-chip stocks. The top three stocks with the highest increase in the number of funds were Wanhua Chemical, China National Offshore Oil Corporation (CNOOC), and Hualu Hengsheng, with increases of 119, 85, and 75 funds respectively [15][19]. 3. Total Market Value and Concentration of Chemical Holdings - The total market value of the top 30 chemical stocks held by public funds increased significantly, with these stocks accounting for 84.68% of the total market value of all heavy chemical stocks, an increase of 3.34 percentage points [24]. - The leading stocks by market value included Wanhua Chemical at approximately 89.41 billion, CNOOC at 67.53 billion, and Juhua Co., Ltd. at 59.78 billion [24].

Core Viewpoint - The petrochemical sector is experiencing a positive trend, with the China Petrochemical Industry Index showing an increase, and significant inflows into the Petrochemical ETF, indicating strong investor interest and potential for growth [1][2]. Group 1: Market Performance - As of January 28, 2026, the China Petrochemical Industry Index rose by 0.54%, with key stocks like Zhejiang Longsheng hitting the daily limit up, and others such as China National Offshore Oil Corporation and Hubei Biopharma also seeing gains [1]. - The Petrochemical ETF (159731) increased by 0.39%, with a turnover rate of 4.34% during the trading session [1]. - Over the past 15 days, the Petrochemical ETF has attracted a total net inflow of 745 million yuan, reaching a record high of 1.018 billion shares and a total size of 1.045 billion yuan [1]. Group 2: Performance Metrics - The Petrochemical ETF has seen a net value increase of 62.39% over the past two years [1]. - The highest monthly return since inception was 15.86%, with the longest streak of consecutive monthly gains being 8 months and a maximum cumulative increase of 41.60% [1]. - The average monthly return during the rising months was 5.25%, and the ETF outperformed its benchmark with an annualized excess return of 2.35% over the past year [1]. Group 3: Industry Outlook - Tianfeng Securities indicates that a turning point in policy and capital expenditure is evident, with the concept of "anti-involution" suggesting improved profitability and healthier long-term development for the industry [1]. - The chemical industry is entering a strategic window, characterized by the exit of high-cost marginal capacity overseas and a restructuring of the global chemical order [1]. Group 4: Top Holdings - As of December 31, 2025, the top ten weighted stocks in the China Petrochemical Industry Index accounted for 56.73% of the index, including Wanhua Chemical, China Petroleum, and China Petrochemical among others [2].

Group 1 - The global chemical industry is transitioning from "overcapacity" to "high-quality supply" by 2026, driven by national growth policies, marginal recovery in overseas demand, and the initiation of a restocking cycle, leading to a stabilization and rebound in the prices of basic chemicals and a significant improvement in industry profit expectations [1][3]. - The E Fund Chemical Industry ETF (516570) has become a core tool for investors to capitalize on the petrochemical industry's recovery, with the index it tracks rising by 15.10% in the past month and 51.39% over the past year as of January 26, 2026 [1][5]. - The ETF has attracted significant capital inflow, with over 180 million yuan in net inflows in the past five days and over 270 million yuan in the past twenty days [1][5]. Group 2 - The "High-Quality Development" policy framework has been established, emphasizing the control of new refining capacities and the scientific regulation of ethylene and paraxylene production, marking a shift from quantity-driven growth to quality and efficiency improvements [3][4]. - A global restocking cycle has commenced, with widespread price increases for chemical products, including a 550 yuan/ton increase for butadiene and a 100 yuan/ton increase for bisphenol A, alongside sulfur prices reaching near ten-year highs [3][4]. - Major international companies like BASF and Dow have also raised prices for MDI/TDI, indicating a strong performance in the polyurethane market, supported by increased global oil demand projected at 950,000 barrels per day for 2026 [4][5]. Group 3 - Chemical companies are expected to report positive earnings, with Salt Lake Co. forecasting a net profit of 8.29 to 8.89 billion yuan for 2025, representing a year-on-year growth of 77.78% to 90.65%, and other companies like Juhua Co. and Cangge Mining also projecting significant profit increases [5][6]. - The E Fund Chemical Industry ETF (516570) tracks the CSI Petrochemical Industry Index, with top holdings including major companies like Wanhua Chemical and China Petroleum, covering over 56% of the index, thus providing a balanced exposure to both energy security and growth in new materials [5][6]. - The ETF has a low comprehensive fee rate of 0.20% per year, making it an ideal tool for participating in the current economic upturn in the chemical sector [5][6].

当英伟达Rubin产品线携MCCP微通道技术呼啸而来，当AI芯片功耗冲破千瓦级物理极限，传统风冷已 触达命运的终局，液冷正从"前沿技术"蜕变为算力时代的"生存标配"。曾几何时，海外巨头垄断核心工 艺、把持价值链顶端，大陆厂商只能在代工赛道捡拾微薄红利，随时面临产能转移的生存危机；而今， 借着AI算力爆发与政策东风，一场以技术破壁、全链自主为核心的国产替代浪潮，正在液冷赛道澎湃 涌动——这不仅是份额的更迭，更是"中国智造"从追赶到引领的韧性史诗，每一步突破都镌刻着坚守， 每一处留白都藏着千亿级的星辰大海。 一、技术破壁：在博弈中突围，啃下"卡脖子"硬骨头 时代的浪潮，从来都眷顾有准备者。当前冷板式液冷以65%的市场份额占据主导，其对现有服务器架构 改动小、部署灵活的优势，成为国产厂商切入市场的最佳跳板。国家"东数西算"工程明确新建数据中心 PUE需低于1.25，四部门专项计划推动液冷技术规模化应用，北上广深更是要求新建智算中心液冷机柜 占比超50%。而液冷技术能将PUE稳定在1.1-1.2区间，远超风冷极限，既是实现"双碳"目标的核心支 撑，更是国产厂商的成长沃土。政策红利与市场需求形成共振，让国产替代从"被动 ...

| 指数 | 收盘 | | 涨跌（％） | | | --- | --- | --- | --- | --- | | 名称 | （点） | 1 日 | 5 日 | 1 月 | | 上证指数 | 4133 | -0.09 | 4.26 | 0.45 | | 深证综指 | 2721 | -0.92 | 7.04 | 0.77 | | 风格指数 | 昨日 | 近 1 个月 | 近 6 个月 | | --- | --- | --- | --- | | (％) | | | | | 大盘指数 | 0 | 0.36 | 13.54 | | 中盘指数 | -0.39 | 11.93 | 34.07 | | 小盘指数 | -1.66 | 10.48 | 26.75 | | 涨幅居前 | 昨日 | 近 1 个月 | 近 6 个月 | | 行业(％) | | | | | 贵金属 | 10.24 | 46.38 | 97.93 | | 动物保健Ⅱ | 5.27 | 16.4 | 31.45 | | 工业金属 | 5.24 | 23.79 | 96.1 | | 小金属Ⅱ | 4.86 | 31.59 | 73.96 | | 饰品 | 4 ...

证券日报网讯 1月26日，巨化股份在互动平台回答投资者提问时表示，公司预计2025年度归属于上市公 司股东的净利润为35.40亿元到39.40亿元，与上年同期相比增加15.80亿元到19.80亿元，同比增长80%到 101%。公司2025年第四季度利润环比有所减少，主要系以下因素的综合影响：一是基于谨慎性原则， 公司根据《企业会计准则》及相关会计政策的要求，对全资子公司衢州巨化锦纶有限责任公司己内酰胺 等部分长期亏损且未来盈利能力存在重大不确定性的生产装置进行了审慎评估，并相应计提了资产减值 准备（详见《公司董事会九届二十三次会议决议公告》）。此项会计处理是基于资产当前状况及未来经 济利益的评估，遵循了会计准则的谨慎性要求，虽对当期利润造成一次性影响，但有利于公司资产质量 的夯实和未来财务表现的健康发展。二是受第四季度下游市场需求阶段性波动及行业季节性因素影响， 公司二代制冷剂产品F22、石化材料、基础化工产品价格环比下降，导致该部分产品的盈利贡献相应减 少。公司管理层始终致力于提升主营业务的核心竞争力和抗风险能力。目前，公司生产经营活动一切正 常，三代制冷剂主要产品价格稳中有升，战略发展项目稳步推进。未来， ...

证券日报网讯 1月26日，巨化股份在互动平台回答投资者提问时表示，公司已于2019年在衢州本埠建立 财务共享中心，主要采用了影刀RPA、通义千问AI等自动化、智能化工具。 （文章来源：证券日报） ...

国海证券研报指出，2025年 巨化股份归母净利润同比大幅提升，看好制冷剂景气持续。公司为制冷剂 全球龙头企业，是国内拥有第一至四代含氟制冷剂系列产品，同时拥有新型含氟冷媒（氢氟醚D系列、 全氟聚醚JHT系列）、碳氢制冷剂产品（3.5万吨/年）以及系列混配制冷剂的生产企业。公司制冷剂生 产配额优势明显，据2026年度氢氟碳化物生产、进口配额核发表，国家核定公司（含控股子公司） HCFC-22生产配额3.84万吨，占全国26.30%，其中内用配额占全国31.55%，为国内第一；HFCs生产配 额29.99万吨，占全国同类品种合计份额的37.58%。同时，公司第四代含氟制冷剂（HFOs）品种及有效 产能国内领先（现运营两套主流HFOs生产装置，产能约8000吨/年；计划通过新建+技术改造新增产能 近5万吨）。公司是全球氟制冷剂龙头企业，制冷剂生产配额领先，随着制冷剂价格上涨，公司有望充 分受益，快速发展。维持"买入"评级。 ...

国海证券研报指出，2025年巨化股份归母净利润同比大幅提升，看好制冷剂景气持续。公司为制冷剂全 球龙头企业，是国内拥有第一至四代含氟制冷剂系列产品，同时拥有新型含氟冷媒（氢氟醚D系列、全 氟聚醚JHT系列）、碳氢制冷剂产品（3.5万吨/年）以及系列混配制冷剂的生产企业。公司制冷剂生产 配额优势明显，据2026年度氢氟碳化物生产、进口配额核发表，国家核定公司（含控股子公司）HCFC- 22生产配额3.84万吨，占全国26.30%，其中内用配额占全国31.55%，为国内第一；HFCs生产配额29.99 万吨，占全国同类品种合计份额的37.58%。同时，公司第四代含氟制冷剂（HFOs）品种及有效产能国 内领先（现运营两套主流HFOs生产装置，产能约8000吨/年；计划通过新建+技术改造新增产能近5万 吨）。公司是全球氟制冷剂龙头企业，制冷剂生产配额领先，随着制冷剂价格上涨，公司有望充分受 益，快速发展。维持"买入"评级。 ...